Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17. In late-breaking data presentations, the ADVANTAGE AF trial for the ...

with a minimally invasive procedure for patients with atrial fibrillation. The WATCHMAN device is a tiny implant that closes off an area of the heart called the left atrial appendage to keep ...

And what exactly is atrial fibrillation anyway ... like warfarin or aspirin — are not candidates for the WATCHMAN device. Another treatment that just came out this year is called pulsed field ...

SGMC Health is raising the bar in cardiac care with the introduction of a cutting-edge Cardiac Electrophysiology (EP) Lab at ...

Atrial fibrillation, or AFib ... An alternative is the WATCHMAN implant, a minimally invasive, one-time procedure to close off the left atrial appendage—a small pouch connected to the upper ...

Similar stroke protection with the WATCHMAN FLX device compared to OAC irrespective ... to improve long-term outcomes for patients with atrial fibrillation," said Dr. Brad Sutton, M.D., chief ...

persistent atrial fibrillation with the FARAPULSE™ Pulsed Field Ablation System Sub-analysis from OPTION clinical trial highlights consistent safety and efficacy outcomes with the WATCHMAN FLX ...

2 In line with the overall 36-month outcomes from this first head-to-head study of the WATCHMAN FLX ... of 1,600 patients with atrial fibrillation who underwent a device implantation either ...